Stayble Therapeutics AB (publ) (STO:STABL)
Sweden · Delayed Price · Currency is SEK 0.1990
+0.0115 (6.13%)
Apr 9, 2026, 5:18 PM CET
Stayble Therapeutics AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
12.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanologica AB | 21.13M |
| Fluicell AB | 15.22M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| AcouSort AB | 10.43M |
| Aptahem AB | 2.59M |
| 2cureX AB | 1.98M |
| NanoEcho AB | 487.00K |
| Lipigon Pharmaceuticals AB | 74.00K |